Reducing exposure to allergic triggers may significantly alleviate the burden of asthma on millions of Americans

Fort Washington, PA (PRWEB) May 18, 2016

Every day, more than 5,400 ER visits and at least 1,200 hospitalizations are a direct result of asthma complications.* Costing more than $56 billion in direct costs annually, asthma remains a critical public health challenge across the country.

“For too many, the suffering associated with uncontrolled asthma can be overwhelmingly disproportionate and better managed,” said Inderpal Randhawa, MD, Associate Clinical Professor of Pediatrics, UC Irvine School of Medicine and Associate Clinical Professor of Medicine, UCLA David Geffen School of Medicine. “A mainstay in asthma management is reducing exposure to allergic triggers – such as mold, smoke and dust. It’s important for anyone suffering with asthma to be tested for such triggers to reduce their risk of an asthma attack and its often avoidable costs and inherent inconveniences.”

A new expert clinical interview on ReachMD highlights a stepwise approach to managing asthma and discuss recommendations for testing for allergic triggers to reduce allergen exposure.

Designed for physicians and other healthcare providers who treat patients with asthma, the program provides a discussion on how the immune system reacts to allergens by producing IgE antibodies, which leads to an allergic reaction and its associated symptoms. The program broadcasts across the ReachMD network including the websites and mobile apps of ReachMD, iHeartRadio, Tunein, iTunes and Stitcher.

“IgE-specific testing helps identify allergic triggers, which in turn helps physicians recommend a patient-focused targeted exposure reduction program,” said Randhawa.“Patients can reduce symptoms and manage their disease, which ultimately improves quality of life and productivity.”

For healthcare providers treating the millions of Americans who suffer from asthma, this program provides key insights into appropriate testing to help guide targeted exposure reduction, as well as guideline-based care regimens.

“Allergy-like symptoms can be very difficult to differentiate from an upper respiratory disease,” said Mario Nacinovich, MSc, host of the program on ReachMD and Managing Partner at Axon Inc. “It is important to help physicians to accurately identify specific allergen sensitivities in order to confirm patient allergies.”

The program is sponsored by Quest Diagnostics.

advertisement | advertise on newsday

About ReachMD
ReachMD lets healthcare professionals Be part of the knowledge® by discovering, participating in, and sharing medical education and clinical information through on demand programming and 24/7 streaming broadcasts. Its multi-channel network provides content online, on mobile, on air, and in enhanced automobiles dashboards. Its broadcast distribution network includes ReachMD, iHeartRadio, TuneIn, Stitcher, iTunes, and Apple Radio. ReachMD is the leading source nationwide of on air, online, and mobile medical education and information. For more information, visit http://www.reachmd.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/allergy/testing/prweb13421627.htm